BioMarin Pharmaceutical Inc. (BMRN) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 4.5% on average (either way), rising 5 times and falling 7. EPS beat estimates 7 of 11 times; revenue 10 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2026-11-02 | 0.23 | -0.05 | n/a | 1.02B | 1.02B | -4.9% |
| Q3 FY2026 | 2026-08-06 | 1.20 | 0.95 | +26.7% | 989.7M | 932.0M | +6.5% |
| Q2 FY2026 | 2026-05-04 | 0.76 | 0.78 | -2.6% | 766.0M | 752.5M | -1.5% |
| Q1 FY2026 | 2026-02-23 | -0.24 | 0.17 | -241.7% | 874.6M | 833.7M | -2.3% |
| Q4 FY2025 | 2025-10-27 | -0.16 | -0.15 | -6.7% | 776.1M | 777.5M | -1.8% |
| Q3 FY2025 | 2025-08-04 | 1.23 | 0.86 | +42.9% | 825.0M | 761.9M | +6.5% |
| Q2 FY2025 | 2025-05-01 | 0.97 | 0.71 | +35.9% | 745.1M | 738.7M | -2.6% |
| Q1 FY2025 | 2025-02-19 | 0.64 | 0.54 | +18.5% | 747.0M | 712.3M | +6.0% |